Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers
- 1 July 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 334 (2) , 319-327
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Multistage Nanovectors: From Concept to Novel Imaging Contrast Agents and TherapeuticsAccounts of Chemical Research, 2011
- The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organsInternational Journal of Cancer, 2011
- In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in miceInternational Journal of Pharmaceutics, 2010
- Logic‐Embedded Vectors for Intracellular Partitioning, Endosomal Escape, and Exocytosis of NanoparticlesSmall, 2010
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Tailoring the degradation kinetics of mesoporous silicon structures through PEGylationJournal of Biomedical Materials Research Part A, 2010
- Tailored Porous Silicon Microparticles: Fabrication and PropertiesChemphyschem, 2010
- Targeting of drugs and nanoparticles to tumorsJournal of Cell Biology, 2010
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic CancerScience, 2009
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005